The peroxisome proliferator-activated receptor-g2 (PPARg2) is almost uniquely expressed in adipose tissue and is of major importance for fat cell differentiation and lipid metabolism. This study was undertaken to assess whether two missense variants in the PPARg2 gene are associated with earlyonset obesity. A previously described polymorphism encoding for an amino acid exchange in codon 12 (Pro12Ala) was detected with allele frequencies of 0.13 in 296 markedly obese children and adolescents and 0
Introduction
Overweight and obesity affect almost half of the population in many industrialized countries. The association with type 2 diabetes, dyslipidemia and hypertension creates increased morbidity and mortality risks for obese individuals. Obesity is viewed as a multifactorial disorder, with genetic factors playing an important pathogenic role.
Products of relevant genes may be involved in the regulation of food intake, energy expenditure or nutrient partitioning. The sum of presumably several genetic effects and their interaction with environmental and behavioral conditions, such as increased caloric and fat intake or decreased physical activity, can result in energy imbalance and increased fat mass.
In recent years, the discovery of leptin and other molecules secreted by fat cells has markedly changed our view of adipose tissue being a rather passive triglyceride store (1) . Furthermore, the peroxisome proliferatoractivated receptor-g2 (PPARg2) was cloned and identified as a central regulator of fat cell differentiation (2, reviewed in 3, 4). PPARg is a transcription factor that belongs to the family of nuclear receptors. Two isoforms, PPARg1 and PPARg2, are formed by alternative promoters and splicing. In contrast to the widespread expression of PPARg1, PPARg2 is almost selectively expressed in adipose tissue. Overexpression of PPARg2 in fibroblast cell lines causes lipid accumulation and differentiation into mature adipocytes (5). PPARg2 mRNA is regulated by several nutritional and hormonal factors in both rodents and humans (6, 7) . Endogenous ligands for PPARg include fatty acids and some prostaglandins, while even more attention has been attracted by the identification of the thiazolidinedione family of insulin sensitizers as acting via PPARg.
Because it is an attractive candidate gene for the dysregulation of energy balance, single strand conformational polymorphism-based screening was applied and two missense variants in the PPARg2 coding sequence were identified (8) (9) (10) . In the unique first exon, a CG base exchange results in a proline to alanine amino acid substitution in codon 12, while a GT base exchange in the second exon shared by both PPARg isoforms introduces a substitution of proline to glutamine in codon 115. Somewhat conflicting data have recently been published as to whether Pro12Ala is associated with obesity (11) or with a lower body mass index (BMI) (12) . In the latter study, a decreased binding affinity of the mutated variant to its promoter response element and a decreased activation of transcription have been demonstrated in various cell lines (12) . Pro115Gln has recently been found in 4 of 121 severely obese individuals (10) . Interestingly, the altered protein causes accelerated adipocyte differentiation and may be directly involved in increased triglyceride accumulation.
Given the above data and the importance of PPARg2 for the regulation of energy storage, this study was undertaken to determine whether missense variants in the PPARg2 gene are associated with early-onset human obesity in a German population.
Subjects and methods
A group of 296 extremely obese children and adolescents was recruited at the Children's Hospital Hochried and the Obesity Treatment Centre Insula, which both specialize in the inpatient treatment of extremely obese young individuals. Ninety-seven percent of the obese subjects had a BMI above the 95th percentile, 61% exceeded the 100th BMI percentile. The second study group of 130 underweight students was selected at the University of Marburg. They were characterized by a BMI below the 13th percentile, absence of somatic disorders and consumption of less than ten cigarettes per day. Probands with anorexia nervosa were excluded from the present sample of underweight individuals that represents an extension of a study group described previously (13) , and both groups have been characterized in detail before (14) .
Genetic studies were approved by the ethics committees of the Universities of Marburg and Hamburg. Written informed consent was obtained from all participants or, in case of minors, their parents.
EDTA anticoagulated venous blood samples were collected from the aforementioned individuals and leukocyte DNA was isolated as described (13) . For restriction fragment length polymorphism (RFLP)-based genotyping, a 306 bp fragment including exon 1 of the human PPARg2 gene and containing the Pro12Ala variant was amplified by PCR using oligonucleotides 5 0 -GCCAATTCAAGCCCAGTC-3 0 and 5 0 -CGTCCCCAA-TAGCCGTATC-3 0 . A 118 bp fragment containing the Pro115Gln variant was amplified using primers 5 0 -AATCAAAGTGGAGCCTGCATGT-3 0 and 5 0 -ATCTCCAC-AGACACGACATT-3 0 . Seventy-five nanograms genomic DNA were added to 20 ml of reaction mixture (14) and amplification over 35 cycles was carried out in an automated thermal cycler at 94 ЊC for 1min, 55ЊC (Pro12Ala) or 50 ЊC (Pro115Gln) for 1 min and 72 ЊC for 2 min. Ten microliters PCR product were digested with HgaI (Pro12Ala) or HincII (Pro115Gln) and subjected to 3% agarose electrophoresis or 10% PAGE with ethidium bromide.
Results
The base exchange predicting the Pro12Ala variant introduces an HgaI site in the amplified sequence, resulting in fragments of 220 and 86 bp for the mutated allele (Fig. 1) .
RFLP analysis revealed an allele frequency of 0.13 for the Pro12Ala variant in 296 obese children and adolescents. Two hundred and twenty (74.3%) were homozygous for the wildtype allele, while seventy three (24.7%) were heterozygous and three (1.0%) were homozygous for the mutated allele.
In the lean group, 95 of 130 individuals (73.1%) were homozygous for the wildtype allele, while 35 (26.9%) were heterozygous for the variant with no homozygotes. Therefore, the frequency of the mutated allele in the lean group (0.14) was not different from the obese (P = 0.98 by x 2 -test). The Pro115Gln variant that should have created an additional HincII site with fragments of 22 and 96 bp, in contrast to the 118 bp wildtype band, was found neither in 296 obese nor in 130 lean individuals.
A DNA fragment including the mutant variant provided by Dr M Ristow (Joslin Diabetes Centre, Boston, MA, USA) was used as a positive control to ensure the correct cut by the restriction enzyme HincII.
Discussion
The importance of PPARg2 in lipid, glucose and energy metabolism is well established. Since PPARg2 promotes adipocyte differentiation, it is an attractive candidate gene for states of altered triglyceride storage, such as obesity or conditions associated with underweight. Variants in the PPARg2 gene could possibly lead to both a decreased or accelerated adipocyte differentiation and lipid accumulation. In a recent study, a variant in codon 115 was demonstrated to be an example of the latter (10) . When a mutated PPARg2 allele previously found in 4 of 121 obese German individuals was overexpressed in murine fibroblasts, it led to a markedly more pronounced adipocyte differentiation than wildtype PPARg2. This is presumably due to the fact that the mutation is next to a serine phosphorylation site in codon 114, which has been shown to be of major importance for the negative regulation of PPARg2 gene expression (15) .
It appeared tempting to speculate that this variant could be associated with early-onset human obesity. However, our RFLP analysis revealed that not a single individual within a large group of morbidly obese children and adolescents or lean individuals carried an allele with the mutation in codon 115. Because both of our study groups are of German origin, it appears that the reported variant (10) is rare in the German population. Thus, it seems unlikely that the Pro115Gln variant explains a relevant proportion of obesity in this population. Furthermore, a previously identified variant in codon 12 was associated neither with obesity nor with leanness.
Although we cannot fully exclude the possibility that an association may be found in other populations, our data make it rather unlikely that variants in the PPARg2 gene contribute to the high prevalence of human obesity.
